| # | Drug | Count |
|---|---|---|
| 0 | FENTANYL | 4 |
| 1 | ACETAMINOPHEN | 3 |
| 2 | ACETAMINOPHEN 500MG | 3 |
| 3 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 3 |
| 4 | DICLOFENAC | 3 |
| 5 | DICLOFENAC SODIUM | 3 |
| 6 | PAIN RELIEVER | 3 |
| 7 | CHLORHEXIDINE GLUCONATE | 2 |
| 8 | MINOXIDIL | 2 |
| 9 | MINOXIDIL FOAM 5% (WOMENS) | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE | 1 | 0.0065 |
| 1 | AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE | 1 | 0.0039 |
| 2 | EPHEDRINE HYDROCHLORIDE | 1 | 0.0022 |
| 3 | ROPIVACAINE HYDROCHLORIDE | 2 | 0.0008 |
| 4 | CHLORHEXIDINE GLUCONATE | 2 | 0.0002 |
| 5 | FOSCARBIDOPA/FOSLEVODOPA | 1 | 0.0001 |
| 6 | PROMETHAZINE HYDROCHLORIDE | 1 | 0.0001 |
| 7 | MINOXIDIL | 2 | 0.0000 |
| 8 | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | 1 | 0.0000 |
| 9 | FENTANYL | 4 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5 |
| 1 | Opioid Agonist [EPC] | 4 |
| 2 | 5-alpha Reductase Inhibitor [EPC] | 2 |
| 3 | Arteriolar Vasodilator [EPC] | 2 |
| 4 | Amide Local Anesthetic [EPC] | 1 |
| 5 | Antiarrhythmic [EPC] | 1 |
| 6 | Calcium [EPC] | 1 |
| 7 | Ester Local Anesthetic [EPC] | 1 |
| 8 | Estrogen [EPC] | 1 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Arteriolar Vasodilator [EPC] | 2 | 0.0000 |
| 1 | Ester Local Anesthetic [EPC] | 1 | 0.0000 |
| 2 | 5-alpha Reductase Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Opioid Agonist [EPC] | 4 | 0.0000 |
| 4 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Non-Standardized Chemical Allergen [EPC] | 1 | 0.0000 |
| 6 | Amide Local Anesthetic [EPC] | 1 | 0.0000 |
| 7 | Antiarrhythmic [EPC] | 1 | 0.0000 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Calcium [EPC] | 1 | 0.0000 |